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Background: The Glasgow Coma Scale (GCS) score of an individual with hypoglycemia is expected to be low due
to an insufficient glucose supply to the brain. However, we sometimes encounter hypoglycemic patients with high
GCS scores. This study was undertaken to analyze the relationship between the GCS score and the plasma glucose
level.
Methods: Among the patients with neurological impairments admitted to our institution between October 1, 2010
and March 31, 2013, the cases of 41 hypoglycemic patients were examined in this retrospective cohort study. The
defined plasma glucose level for mild hypoglycemia was 41–60 mg/dL, that for moderate hypoglycemia was 21–40
mg/dL, and that for extreme hypoglycemia was below 20 mg/dL. We divided the patients into two groups: those
with mild hypoglycemia (n = 14) and those with moderate/extreme hypoglycemia (n = 27). We compared the two
groups' physiological data and assessed the relationship between the GCS score and the plasma glucose level by
Spearman rank correlation (ρ), the significance of which was determined by Spearman's rank sum test. We used the
Mann-Whitney U-test and the chi-square (χ2) test to test for differences between the two groups when appropriate.
Results: Three hundred twenty-six patients with neurological impairments were admitted during the study period,
and 41were eligible hypoglycemic patients. The GCS scores of the 14 patients with mild hypoglycemia were
significantly higher than those of the 27 patients with moderate or extreme hypoglycemia (median score 12, range
7–15 vs. 10, 3–15, p = 0.0367). There were no significant differences in physiological data (including autonomic
symptoms) between the two groups. Spearman's rank sum test was 0.491 in the total group of 41 hypoglycemic
patients, 0.053 in the mild hypoglycemic patients, and 0.493 in the moderately or extremely hypoglycemic patients.
Conclusions: The relationship between the GCS score and the plasma glucose level differed according to the
severity of hypoglycemia. Even when a patient has a high GCS score, careful assessment of differential diagnosis
should be conducted and the possibility of hypoglycemia should be considered in light of his or her neurogenous
symptoms.
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The Glasgow Coma Scale (GCS) was developed to de-
scribe the level of consciousness in patients with trau-
matic brain injury [1]. It measures the patients' best eye,
motor, and verbal responses, and it classifies the level of
consciousness as mild (score of 14–15), moderate (9–13),* Correspondence: w03tfpd922@hi3.enjoy.ne.jp
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reproduction in any medium, provided the oror severe (3–8) [2]. The GCS is also used for describing
the level of consciousness in hypoglycemic patients [3],
and it is widely accepted as a tool for both trauma and
non‐trauma patients.
Hypoglycemic patients commonly have neuroglycope-
nic symptoms. The GCS score of hypoglycemic patients
is predicted to be low because the glucose supply to the
brain is insufficient. However, we sometimes encounter
the hypoglycemic patients with high GCS scores. There
are few reports concerning the relationship between theLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patients. In the present study, we analyzed the relationship
between these two parameters according to the severity of
hypoglycemia and compared the physiological data among
patients with differing degrees of hypoglycemia.
Methods
Patients
We investigated patients age 18 and over who were
transferred to our institution with neurological impair-
ments between October 1, 2010 and March 31, 2013.
Among those patients, only the hypoglycemic patients
were eligible for the present study. Hypoglycemia was de-
fined as a plasma glucose level below 60 mg/dL, accom-
panied by a wide variety of symptoms [4]. We also used
the following definitions: mild hypoglycemia, a plasma
glucose level of 41–60 mg/dL; moderate hypoglycemia,
21–40 mg/dL; extreme hypoglycemia, below 20 mg/dL
[4]. We usually perform the sampling of either arterial
blood or capillary blood rapidly and check the glucose
level by arterial blood gas analyzer or glucose meter. The
choice of the material and the device is committed to each
emergency physician. On the other hand, we also perform
the sampling of venous blood without delay, and the
plasma glucose level per patient is measured by glucose
oxidase method in a central laboratory. Thus, in the
present study, we used the sample of venous blood.
Protocol design
This was a retrospective cohort study. All data were
obtained from medical charts and did not include any per-
sonal information that would identify any of the patients.
Therefore, informed consent from the patients was waived,
based on the Ethical Guidelines for Epidemiological Studies
issued jointly by the Ministry of Health, Labour and
Welfare and the Ministry of Education, Culture, Sports,
Science, and Technology of Japan.
Data collection
The data collected from medical charts were age, gender,
symptoms, GCS score, renal dysfunction, diabetes melli-
tus (DM) status, body temperature, heart rate, systolic
blood pressure, and plasma glucose level. Lucidity was
defined as GCS score of 15, mild confusion was GCS of
14, moderate confusion was GCS of 9–13, and severe
confusion or coma was GCS of 3–8 [2]. Estimation of
the level of consciousness by the GCS score and sam-
pling of the venous blood to measure the plasma glucose
level were performed at the same time as part of the
Emergency Room visit.
We divided the patients into two groups: the mild
hypoglycemia group and the moderate/extreme hypo-
glycemia group. The physiological data of the two
groups were compared. Renal dysfunction was definedas a glomerular filtration rate (GFR) less than 60 mL/min
[5]. In our study, the GFR was assessed by determining
the estimated GFR. DM was defined according to the
World Health Organization criteria as the presence of ei-
ther fasting venous plasma glucose levels of 7.0 mmol/L
(126 mg/dL) or greater, or 2-h venous plasma glucose
levels of 11.1 mmol/L (200 mg/dL) or greater, or a 75 g
oral glucose tolerance test result [6].
Statistical analysis
All statistical analyses were performed using the soft-
ware programs SPSS 17.0 (SPSS, Chicago, IL, USA) and
Excel Tokei 2012 (Social Survey Research Information
Co., Tokyo, Japan). Intergroup differences were assessed
with the χ2 test with Yates' correlation for continuity in
categorical variables. The Mann-Whitney U test was
used to test for differences in continuous variables. We
considered p values <0.05 significant. We analyzed the
correlation between the GCS score and plasma glucose
level by Spearman rank correlation (ρ), the significance
of which was determined by Spearman's rank sum test.
Results
The number of patients with neurological impairments
admitted to our institution during the study term was
326 of the 3,514 patients, and 41 of these 326 patients
were hypoglycemic. The median plasma glucose level in
the 41 patients was 32 mg/dL (range, 10–58 mg/dL).
The number of patients with mild hypoglycemia was 14,
that of patients with moderate hypoglycemia was 21, and
that of patients with extreme hypoglycemia was 6. Because
the number of patients with extreme hypoglycemia was
small, we divided the patients into the two groups of mild
hypoglycemia and moderate/extreme hypoglycemia.
The symptoms of the two groups were shown in
Table 1. The symptoms in the mild hypoglycemia group
were confusion in ten patients (two mild, seven moder-
ate, and one severe), difficulty in speech in one patient,
weakness in two patients, and convulsions in one patient.
The symptoms in the moderate/extreme hypoglycemia
group were confusion in 26 patients (4 mild, 12 moderate,
and 10 severe) and weakness in 1 patient. Several patients
complained of various neurological impairments besides
confusion.
The causes of hypoglycemia in the two groups were
shown in Table 2. Of the 41 patients, 33 patients had DM,
24 were treated with insulin, and 9 were treated with oral
anti‐diabetic agents. Ten patients had insulin‐dependent
DM, and 23 patients had non-insulin‐dependent DM. The
common causes of hypoglycemia in the diabetic patients
were low calorie intake due to illness or dieting (23/33)
and suspected overdose of insulin or oral anti‐diabetic
agents (5/33). The causes in the non‐diabetic patients
were various: malnutrition due to chemotherapy in two









Confusion 10 26 36




Severe (GCS score of
3–8)
1 10d 11
Difficulty in speech 1 - 1
Weakness 2 1 3
Convulsions 1 - 1
Total 14 27 41
aIn the seven patients, difficulty in speech, convulsions, or weakness was
observed in each patient; bin the four patients, difficulty in speech or left
hemiplegia was observed in each patient; cin the 12 patients, 1 had
convulsions; din the ten patients, two had convulsions.
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secreting insulin-like growth factor II, sudden withdrawal
from long-term steroid treatment, dumping syndrome,
and alcoholism (one patient each). In the mild hypo-
glycemia group, 11 patients had DM and the other 3 did
not. The moderate/extreme hypoglycemia group included
22 patients with DM and 5 without.
The groups' physiological data (in medians and ranges)
are provided in Table 3. There were no significant differ-
ences between the two hypoglycemia groups in age, gen-
der, renal dysfunction, rate of DM, body temperature,
heart rate, or systolic blood pressure. However, the GCS
scores in the mild hypoglycemia group were significantly
higher than those in the moderate/extreme hypoglycemiaTable 2 The causes of hypoglycemia in the two groups
The causes of hypoglycemia
With DM (N = 33) Low calorie intake due to illness or dieting
Over dose of anti-diabetic therapy
Malnutrition due to chemotherapy
Unclear
Without DM (N = 8) Malnutrition due to chemotherapy
Anorexia nervosa
Hepatocellular carcinoma secreting ILGF II





DM diabetes mellitus, ILGF II insulin-like growth factor II.group (median GCS score 12, range 7–15, vs. 10, 3–15,
p = 0.0367).
Figures 1 and 2 demonstrate the relationship between
the GCS scores and the plasma glucose levels. The GCS
scores were significantly correlated with the plasma glu-
cose levels in the total hypoglycemic patients (Figure 1a,
ρ = 0.491, p < 0.01) and in the moderate/extreme hypo-
glycemia group (Figure 1b, ρ = 0.493, p < 0.01). However,
in the mild hypoglycemia group, the GCS scores were
not correlated with plasma glucose levels (Figure 1c,
ρ = 0.053, p = 0.857). The relationship was significant in
the diabetic patients (Figure 2a, ρ = 0.458, p < 0.05), but
not significant in the non‐diabetic patients; nevertheless,
the value of Spearman's rank sum test was high (Figure 2b,
ρ = 0.627, p = 0.096).
Discussion
The relationship between the GCS scores and the plasma
glucose levels was significant in the total hypoglycemic pa-
tients and in the moderate/extreme hypoglycemia group.
However, the number of patients in the mild hypo-
glycemia group is small and the relationship was not
significant. We considered the mechanisms that might
underlie this discrepancy.
In general, neuroglycopenic symptoms are observed
when an individual's plasma glucose level reaches approxi-
mately 50–60 mg/dL [7]. It was reported that the plasma
glucose level at which cognitive dysfunction was observed
was approximately 57 mg/dL [8], the level for neurogen-
ous symptoms was approximately 55 mg/dL, the level for
disorders of mental function was 46 mg/dL, and the level
for convulsions or coma was 27 mg/dL [9]; however, these
levels varied among the patients [9]. Of the strictly regu-















Table 3 The physiological data on admission between the two groups
Mild hypoglycemia group Moderate/extreme hypoglycemia group p value
Plasma glucose level (mg/dL) 47 (42–58) 28 (10–40) -
Age (years) 65 (29–95) 67 (26–84) 0.4828
Gender Male/female = 8:6 Male/female = 18:9 0.5483
Estimated GFR (mL/min) 53 (8–90) 67 (10–90) 0.2405
Diabetes mellitus status 11/14 (91%) 22/27 (76.7%) 0.8236
GCS score 12 (7–15) 10 (3–15) 0.0367
Body temperature (°C) 36.1 (34.8–36.6) 35.9 (29.6–37.3) 0.2648
Heart rate (beats/min) 87 (48–127) 86 (62–126) 0.8044
Systolic blood pressure (mmHg) 137 (90–198) 138 (92–198) 0.9561
GFR glomerular filtration rate, GCS Glasgow Coma Scale.
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cose levels at the onset of neuroglycopenic symptoms
might have declined further [9]. In addition, recurrent
hypoglycemic episodes can weaken the adrenalin and glu-
cagon response to decreased plasma glucose levels, and
severe hypoglycemia can be induced [9]. This weakened
response was recently named hypoglycemia-associated
autonomic failure (HAAF), and it was described as a po-
tential risk factor for ‘hypoglycemia unawareness’ [9-11].
Conversely, in the poorly controlled diabetic patients of
the same study, the plasma glucose levels at the onset of
neuroglycopenic symptoms became higher [9,12].
In the 33 diabetic patients, 27 had recurrent hypo-
glycemic episodes, 3 had no episodes, and 3 were un-
clear. The median (range) GCS scores and plasma
glucose levels in the diabetic patients with versus (vs.)
without recurrent hypoglycemic episodes were 11 (3–15)
and 33 mg/dL (18–58 mg/dL) vs. 10 (3–12) and 28 mg/dLFigure 1 Scatter graph demonstrating the relationship between the G
Spearman's rank sum test was statistically high (ρ = 0.493) in the total hypo
statistically high (ρ = 0.491) in the moderate or extreme hypoglycemic patie
in the mild hypoglycemic patients.(25–47 mg/dL) (not significant). The number of diabetic
patients without recurrent hypoglycemic episodes was
small, and it was difficult to elucidate the effect of recur-
rent hypoglycemic episodes statistically in the diabetic
patients.
The hemoglobinA1c (HbA1c) level indicates whether
DM is well controlled or not, and it reflect the patients'
glycemic condition for the prior 3–4 months [13]. Un-
fortunately, the HbA1c within 3–4 months of the date
on which a hypoglycemic episode occurred was not mea-
sured in 9 of the 33 diabetic patients. The median (range)
HbA1c level was 6.3% (5.3%–11.8%); however, this level
did not reflect the data of all the diabetic patients, and the
analysis was not enough to predict whether DM was well
controlled or not.
On the other hand, four of the nine patients treated
with oral anti‐diabetic agents were medicated with two
or three kinds of anti‐diabetic agents. The median (range)CS scores and the plasma glucose levels. (a) The value of the
glycemic patients. (b) The value of the Spearman's rank sum test was
nts. (c) The value of the Spearman's rank sum test was low (ρ = 0.053)
Figure 2 Scatter graph demonstrating the relationship between the GCS scores and the plasma glucose levels. Closed circles indicate
the patients who had recurrent hypoglycemic episodes. Open circles indicate the patients who had no hypoglycemic episodes. Open triangles
indicate the patients whose hypoglycemic episodes were unclear. (a) The value of the Spearman's rank sum test was statistically high (ρ = 0.458)
in the diabetic patients. (b) The value of the Spearman's rank sum test was high (ρ = 0.627) in the non-diabetic patients, but not significant.
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24 patients treated with insulin, and the dosage was
equivalent to that in other studies [14,15]. Indeed, hypo-
glycemia induced by the overdose of insulin therapy or
oral anti‐diabetic agents was observed in five patients, and
almost all of the diabetic patients had experienced recur-
rent hypoglycemic episodes. Furthermore, the median
plasma glucose level in the diabetic patients of the present
study was lower than that in the poorly controlled diabetic
patients of the other study (33 vs. 78 mg/dL) [12]. Consid-
ering these data, it appears that almost all of the diabetic
patients in the present study are thought to be strictly
controlled.
In the eight non‐diabetic patients, four had recurrent
hypoglycemic episodes and four did not have. The me-
dian (range) GCS scores and plasma glucose levels in
the patients with vs. without recurrent hypoglycemic ep-
isodes were 10 (3–12) and 20 mg/dL (10–32 mg/dL) vs.
13 (10–14) and 42 mg/dL (30–47 mg/dL). The plasma
glucose levels were significantly lower in the patients
with recurrent hypoglycemic episodes (p = 0.0421), but
there was no significant difference in the GCS scores.
The number of patients is small; however, we can con-
struct the hypothesis that the plasma glucose levels at the
onset of neuroglycopenic symptoms decline due to recur-
rent hypoglycemic episodes in the non‐diabetic patients.
The recurrent hypoglycemic episodes and the strict
management for DM would shift the plasma glucose
levels at the onset of neuroglycopenic symptoms to the
lower levels, and that may have contributed to the dis-
crepancy in the Spearman's rank sum test. When theplasma glucose levels were 41–60 mg/dL, the levels were
not low enough to cause severe neurogenous symptoms
and the GCS scores did not correlate with the plasma
glucose levels. Conversely, when the plasma glucose
levels were below 40 mg/dL, the levels were low enough
to cause severe neurogenous symptoms in almost all of
the patients and the GCS scores were significantly corre-
lated with the plasma glucose levels. The cause of the
declined plasma glucose levels at the onset of neuroglyco-
penic symptoms might be different between the diabetic
and non‐diabetic patients; however, the high frequency of
moderate or extreme hypoglycemia had contributed to
the high value of Spearman's rank sum test in the diabetic
and non-diabetic patients. In the future, even when a
patient has a high GCS score, a careful assessment of dif-
ferential diagnosis should be made, and the treating physi-
cians should consider the possibility of hypoglycemia in
light of the patient's various neurogenous symptoms.
Hypoglycemia also causes autonomic symptoms that
show dependence on the according to plasma glucose
levels [7,9]. The increased levels of glucagon and adren-
aline could cause tachycardia or hypertension. The re-
ported plasma glucose levels of each autonomic symptom
were as follows: increased glucagon secretion at 69 mg/dL,
increased adrenalin secretion at 66 mg/dL, and increased
cortisol secretion at 57 mg/dL [9]. There were no signifi-
cant differences in heart rate or systolic blood pressure be-
tween the two groups. Heart rate or systolic blood pressure
was influenced by anti‐hypertensive drugs. Indeed, in the
present study, 24 of the 41 patients were medicated with
anti‐hypertensive drugs. The level of adrenalin, glucagon,
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could not detect any differences in autonomic symptoms
according to the plasma glucose levels. We will conduct
such an analysis in the future.
There are several limitations in this study. The sample
size of patients was small, and the data reflect the ex-
perience of a single center. Thus, the results may not be
generalized for the population as a whole. Ongoing trials
and reexamination with a large number of patients at sev-
eral centers are necessary to test the results in the present
study. In addition, the study was a retrospective investiga-
tion. Further examinations are needed to evaluate the re-
sults after measuring the adrenaline, glucagon, and cortisol
levels in hypoglycemic patients. Finally, Inoue et al. [16]
reported the difference of the accuracy of blood-glucose
measurements between arterial blood gas analyzers and
glucose meters by using arterial blood or capillary blood. It
should be noted that a choice of the blood sample or the
device could influence the blood glucose levels.
Conclusions
The relationship between the GCS scores and the plasma
glucose levels differed according to the severity of the pa-
tients’ hypoglycemia. Even when a patient has a high GCS
score, his or her differential diagnosis should be carefully
evaluated and the possibility of hypoglycemia should be
considered in light of various neurogenous symptoms.
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